backward compatibility test from 2.38

SF--(BUSINESS WIRE)--This press release contains statements that relate to future events and expectations, including those relating to the proposed notes offering, the intended use of the net proceeds from the issuance of the notes and the Tender Offers, and as such constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.

Forward-looking statements include those containing such words as “aims,” “ambition,” “anticipates,” “believes,” “could,” “develop,” “endeavors,” “estimates,” “expects,” “forecasts,” “goal,” “intends,” “may,” “outlook,” “potential,” “plans,” “projects,” “reach,” “seeks,” “sees,” “should,” “strive,” “targets,” “will,” “working,” “would,” or other words of similar meaning.

All statements by TEST that reflect expectations, assumptions or projections about the future, other than statements of historical fact, are forward-looking statements. Forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties, and changes in circumstances that are difficult to predict.

Although TEST believes that the expectations reflected in any forward-looking statements are based on reasonable assumptions, it can give no assurance that these expectations will be attained and it is possible that actual results may differ materially from those indicated by these forward-looking statements due to a variety of risks and uncertainties.

XYZ CORPORATION
Consolidated Income Statements
(in thousands, except per share amounts)
Unaudited
		Three Months Ended					Nine Months Ended
		September 30,			September 30,		September 30,			September 30,
			2006			2005		2006			2005
Revenues:
	Product sales	$	2,035,652		$	1,687,277	$	5,717,780		$	4,996,110
	Services		779,654			678,465		2,222,736			1,957,578
			2,815,306			2,365,742		7,940,516			6,953,688
Cost and expenses:
	Cost of product sales		992,272			813,760		2,794,910			2,425,379
	Cost of services		339,295			274,365		970,532			819,829
	Research and development		312,302			254,720		895,220			742,359
	Selling, general and administrative		809,086			641,219		2,339,326			1,899,619
	In-process research and development		23,000			-		35,410			3,100
	Restructuring charges (credits)		(2,779	)		5,849		(4,359	)		3,717
Operating income			342,130			375,829		909,477			1,059,685

Additional information concerning factors that could cause actual results to differ materially from those projected in the forward-looking statements is contained in TEST’s filings with the Securities and Exchange Commission. TEST disclaims any obligation to update publicly any forward-looking statements, whether in response to new information, future events or otherwise, except as required by applicable law.